UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 384

Sortiert nach

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

The Lancet (British edition), 2015-09, Vol.386 (9998), p.1049-1056

2015

Volltextzugriff (PDF)

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin

BMC cancer, 2012-12, Vol.12 (1), p.571-571, Article 571

2012

Volltextzugriff (PDF)

Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial

Lung cancer (Amsterdam, Netherlands), 2023-01, Vol.175, p.141-151

2023

Volltextzugriff (PDF)

ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development

European journal of cancer (1990), 2012-05, Vol.48 (7), p.961-973

2012

Volltextzugriff (PDF)

Functional inactivation of NF2/merlin in human mesothelioma

Lung cancer (Amsterdam, Netherlands), 2009-05, Vol.64 (2), p.140-147

2009

Volltextzugriff (PDF)

Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial

Journal of thoracic oncology, 2020-03, Vol.15 (3), p.416-425

2020

Volltextzugriff (PDF)

Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma

Journal of clinical oncology, 2004-09, Vol.22 (17), p.3451-3457

2004

Volltextzugriff (PDF)

Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial

Radiotherapy and oncology, 2019-09, Vol.138, p.121-125

2019

Volltextzugriff (PDF)

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Journal of clinical oncology, 2004-10, Vol.22 (20), p.4157-4164

2004

Volltextzugriff (PDF)

Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy

PloS one, 2012-09, Vol.7 (9), p.e45354

2012

Volltextzugriff (PDF)

Inhibition of REV3 Expression Induces Persistent DNA Damage and Growth Arrest in Cancer Cells

Neoplasia (New York, N.Y.), 2011-10, Vol.13 (10), p.961-IN28

2011

Volltextzugriff (PDF)

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma

Journal for immunotherapy of cancer, 2023-10, Vol.11 (10), p.e007585

2023

Volltextzugriff (PDF)

Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma

Lung cancer (Amsterdam, Netherlands), 2010-03, Vol.67 (3), p.311-317

2010

Volltextzugriff (PDF)

Etiology of Solitary Extrapulmonary Positron Emission Tomography and Computed Tomography Findings in Patients With Lung Cancer

Journal of clinical oncology, 2005-10, Vol.23 (28), p.6846-6853

2005

Volltextzugriff (PDF)

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma

Frontiers in genetics, 2017-05, Vol.8, p.70-70

2017

Volltextzugriff (PDF)

Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

Journal of thoracic oncology, 2019-06, Vol.14 (6), p.1086-1094

2019

Volltextzugriff (PDF)

GAS5 long non-coding RNA in malignant pleural mesothelioma

Molecular cancer, 2014-05, Vol.13 (1), p.119-119, Article 119

2014

Volltextzugriff (PDF)

A Recombinant Immunotoxin Derived from a Humanized Epithelial Cell Adhesion Molecule-specific Single-Chain Antibody Fragment Has Potent and Selective Antitumor Activity

Clinical cancer research, 2003-07, Vol.9 (7), p.2837-2848

2003

Volltextzugriff (PDF)

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Molecular cancer, 2007-10, Vol.6 (1), p.66-66, Article 66

2007

Volltextzugriff (PDF)

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Journal of clinical oncology, 2014-09, Vol.32 (25), p.2780-2787

2014

Volltextzugriff (PDF)

Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial

The Journal of thoracic and cardiovascular surgery, 2020-01, Vol.159 (1), p.330-340.e4

2020

Volltextzugriff (PDF)

Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?

Current opinion in oncology, 2009-03, Vol.21 (2), p.124-130

2009

Volltextzugriff (PDF)

1 – 25 von 384

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(354)
Mit Volltextzugriff
(373)

Publikationsform

Sprache

Englisch
(383)
Japanisch
(60)
Russisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(257)
Life Sciences & Biomedicine
(253)
Humans
(239)
Oncology
(212)
Biological And Medical Sciences
(108)
Medical Sciences
(107)
Female
(93)
Male
(86)
Middle Aged
(73)
Respiratory System
(68)
Aged
(65)
Adult
(62)
Pneumology
(56)
Tumors Of The Respiratory System And Mediastinum
(54)
Tumors
(53)
Lung Neoplasms - Pathology
(51)
Prognosis
(50)
Neoplasm Staging
(49)
Lung Neoplasms - Drug Therapy
(41)
Chemotherapy
(37)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Induction chemoradiation in stage IIIA/N2 non-small-cell lung cancer: a phase 3 randomised trial

Starvation-induced activation of ATM/Chk2/p53 signaling sensitizes cancer cells to cisplatin

Neoadjuvant chemotherapy and extrapleural pneumonectomy of malignant pleural mesothelioma with or without hemithoracic radiotherapy (SAKK 17/04): a randomised, international, multicentre phase 2 trial

Assessment of RANK/RANK-L prevalence and clinical significance in NSCLC European Thoracic Oncology Platform Lungscape cohort and SPLENDOUR randomized clinical trial

ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development

Functional inactivation of NF2/merlin in human mesothelioma

Evolution and Clinical Impact of EGFR Mutations in Circulating Free DNA in the BELIEF Trial

Neoadjuvant Chemotherapy Followed by Extrapleural Pneumonectomy in Malignant Pleural Mesothelioma

Pattern of failure after adjuvant radiotherapy following extrapleural pneumonectomy of pleural mesothelioma in the SAKK 17/04 trial

Circulating Deoxyribonucleic Acid As Prognostic Marker in Non–Small-Cell Lung Cancer Patients Undergoing Chemotherapy

Differential effects of lovastatin on cisplatin responses in normal human mesothelial cells versus cancer cells: implication for therapy

Inhibition of REV3 Expression Induces Persistent DNA Damage and Growth Arrest in Cancer Cells

Neoadjuvant chemotherapy and radiotherapy followed by surgery in selected patients with stage IIIB non-small-cell lung cancer: a multicentre phase II trial

PD-1-expressing macrophages and CD8 T cells are independent predictors of clinical benefit from PD-1 inhibition in advanced mesothelioma

Combined FDG-PET/CT in response evaluation of malignant pleural mesothelioma

Etiology of Solitary Extrapulmonary Positron Emission Tomography and Computed Tomography Findings in Patients With Lung Cancer

Posttranscriptional Regulation Controls Calretinin Expression in Malignant Pleural Mesothelioma

Progression-Free and Overall Survival for Concurrent Nivolumab With Standard Concurrent Chemoradiotherapy in Locally Advanced Stage IIIA-B NSCLC: Results From the European Thoracic Oncology Platform NICOLAS Phase II Trial (European Thoracic Oncology Platform 6-14)

Afatinib in NSCLC With HER2 Mutations: Results of the Prospective, Open-Label Phase II NICHE Trial of European Thoracic Oncology Platform (ETOP)

GAS5 long non-coding RNA in malignant pleural mesothelioma

A Recombinant Immunotoxin Derived from a Humanized Epithelial Cell Adhesion Molecule-specific Single-Chain Antibody Fragment Has Potent and Selective Antitumor Activity

Human agonistic TRAIL receptor antibodies Mapatumumab and Lexatumumab induce apoptosis in malignant mesothelioma and act synergistically with cisplatin

Prevalence and clinical outcomes for patients with ALK-positive resected stage I to III adenocarcinoma: results from the European Thoracic Oncology Platform Lungscape Project

Intracavitary cisplatin-fibrin chemotherapy after surgery for malignant pleural mesothelioma: A phase I trial

Improving the outcome in malignant pleural mesothelioma: nonaggressive or aggressive approach?

Suchergebnisse filtern